Michael R. Mulvey
Nosocomial Infections
National Microbiology Laboratory
Health Canada
Winnipeg
Canada
Name/email consistency: high
- Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Mulvey, M.R., Bryce, E., Boyd, D.A., Ofner-Agostini, M., Land, A.M., Simor, A.E., Paton, S. Antimicrob. Agents Chemother. (2005)
- Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Mulvey, M.R., Bryce, E., Boyd, D., Ofner-Agostini, M., Christianson, S., Simor, A.E., Paton, S. Antimicrob. Agents Chemother. (2004)
- Characterization of a Salmonella enterica serovar Agona strain harbouring a class 1 integron containing novel OXA-type beta-lactamase (blaOXA-53) and 6'-N-aminoglycoside acetyltransferase genes [aac(6')-I30]. Mulvey, M.R., Boyd, D.A., Baker, L., Mykytczuk, O., Reis, E.M., Asensi, M.D., Rodrigues, D.P., Ng, L.K. J. Antimicrob. Chemother. (2004)
- Emergence of multidrug-resistant Salmonella Paratyphi B dT+, Canada. Mulvey, M.R., Boyd, D., Cloeckaert, A., Ahmed, R., Ng, L.K. Emerging Infect. Dis. (2004)
- Characterization of the first extended-spectrum beta-lactamase-producing Salmonella isolate identified in Canada. Mulvey, M.R., Soule, G., Boyd, D., Demczuk, W., Ahmed, R. J. Clin. Microbiol. (2003)